Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Prostate Cancer After Surgery”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Testing effectiveness (Phase 2)Study completedNCT03515577
What this trial is testing

Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After Surgery

Who this might be right for
Recurrent Prostate Carcinoma
Jonsson Comprehensive Cancer Center 50
Not applicableUnknownNCT06154499
What this trial is testing

Archive Prostate. Observational Study of Patients Who Underwent Radical Prostatectomy Surgery

Who this might be right for
Prostate Cancer
IRCCS San Raffaele 1,784
Testing effectiveness (Phase 2)Active Not RecruitingNCT03809000
What this trial is testing

Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery

Who this might be right for
Prostate Cancer
RTOG Foundation, Inc. 188
Testing effectiveness (Phase 2)Looking for participantsNCT05946824
What this trial is testing

This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned.

Who this might be right for
Recurrent Prostate Cancer After Surgery
University of Rochester 80
Testing effectiveness (Phase 2)Study completedNCT00166426
What this trial is testing

Exisulind Versus Placebo After Surgical Removal of the Prostate

Who this might be right for
Prostatic Neoplasms
Mayo Clinic 240
Not applicableLooking for participantsNCT06941363
What this trial is testing

Salvage Ultrahypofractionated Postoperative External Radiotherapy For Biochemical Recurrence

Who this might be right for
Prostate Cancer (Post Prostatectomy)
University of Milano Bicocca 50
Testing effectiveness (Phase 2)WithdrawnNCT00003858
What this trial is testing

Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology
Large-scale testing (Phase 3)Looking for participantsNCT04794777
What this trial is testing

Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer

Who this might be right for
Prostate Cancer
Stefan Carlsson 450
Early research (Phase 1)Study completedNCT04428203
What this trial is testing

Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer RecurrentProstate CancerProstate Adenocarcinoma
Zin W Myint 21
Testing effectiveness (Phase 2)Looking for participantsNCT06617481
What this trial is testing

PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence

Who this might be right for
Prostate Cancer (Post Prostatectomy)
AdventHealth 30
Early research (Phase 1)Active Not RecruitingNCT01923506
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery

Who this might be right for
Recurrent Prostate CancerStage I Prostate CancerStage IIA Prostate Cancer+2 more
City of Hope Medical Center 26
Large-scale testing (Phase 3)Study completedNCT00765479
What this trial is testing

Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
University of Illinois at Chicago 284
Not applicableStudy completedNCT01123434
What this trial is testing

Immediate Postoperative Adjuvant Hormonal Treatment in High Risk Localised or Locally Advanced Prostate Cancer Patients.

Who this might be right for
2 Years PSA Recurrence Rate
AstraZeneca 200
Testing effectiveness (Phase 2)Ended earlyNCT02420652
What this trial is testing

Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy

Who this might be right for
Recurrent Prostate CarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more
Rutgers, The State University of New Jersey 27
Not applicableNot Yet RecruitingNCT07483658
What this trial is testing

Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.

Who this might be right for
Reccurent/Metastatic Solid Tumor DiseaseProstate Cancer (Post Prostatectomy)Prostate Cancer+3 more
CHU de Quebec-Universite Laval 434
Not applicableStudy completedNCT00336934
What this trial is testing

Pomegranate Extract in Treating Patients With Rising Prostate-Specific Antigen Levels After Surgery or Radiation Therapy for Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Roll International Corporation 183
Large-scale testing (Phase 3)Study completedNCT01272050
What this trial is testing

Radiation Therapy in Treating Patients With Relapsed Prostate Cancer After Surgery

Who this might be right for
Prostate Cancer
Swiss Cancer Institute 350
Not applicableStudy completedNCT02155998
What this trial is testing

Non-Interventional Study PREVENT

Who this might be right for
Postoperative or Postradiation Adjuvant Androgen Deprivation Therapy in Locally Advanced Prostate Cancer (High and Very High Risk) Patients
AstraZeneca 200
Large-scale testing (Phase 3)Looking for participantsNCT04423211
What this trial is testing

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Prostate CarcinomaProstate Adenocarcinoma+1 more
ECOG-ACRIN Cancer Research Group 804
Not applicableUnknownNCT02181192
What this trial is testing

Point in Time of Radiotherapy for Patients With Biochemical Recurrent Prostate Carcinoma

Who this might be right for
Prostate CancerRecurrence
University of Erlangen-Nürnberg Medical School 180
Load More Results